These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13807116)

  • 1. [On euglobulin fibrinolysis. I. The characteristics of euglobulin fibrinolysis in normal man].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1370-3. PubMed ID: 13807116
    [No Abstract]   [Full Text] [Related]  

  • 2. [On euglobulin fibrinolysis. II. The characteristics of euglobulin fibrinolysis in arterisclerotic subjects].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1373-5. PubMed ID: 13807117
    [No Abstract]   [Full Text] [Related]  

  • 3. [On euglobulin fibrinolysis. III. Primary data on the characteristics of euglobulin fibrinolysis in infective diseases and in neoplasms].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1375-6. PubMed ID: 13807118
    [No Abstract]   [Full Text] [Related]  

  • 4. A micromethod of euglobulin fibrinolysis in plasma of human subjects and small laboratory animals.
    COPLEY AL; NIEWIAROWSKI S; MARECHAL J
    J Lab Clin Med; 1959 Mar; 53(3):468-73. PubMed ID: 13631330
    [No Abstract]   [Full Text] [Related]  

  • 5. C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis.
    Kluft C
    Thromb Res; 1978 Aug; 13(2):135-51. PubMed ID: 694838
    [No Abstract]   [Full Text] [Related]  

  • 6. Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator.
    Kluft C
    Haemostasis; 1977; 6(6):351-69. PubMed ID: 611048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the euglobulin method for the determination of fibrinolysis.
    KOWALSKI E; KOPEC M; NIEWIAROWSKI
    J Clin Pathol; 1959 May; 12(3):215-8. PubMed ID: 13654539
    [No Abstract]   [Full Text] [Related]  

  • 8. Euglobulin lysis time in fresh and stored samples.
    Prisco D; Paniccia R; Bandinelli B; Filippini M; Brunelli T; Zarone N; Francalanci I; Abbate R
    Am J Clin Pathol; 1994 Dec; 102(6):794-6. PubMed ID: 7801893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the ratio of the euglobulin clot lysis time and fibrinogen content in euglobulin (author's transl)].
    Matsuo T; Matsunaga K
    Rinsho Ketsueki; 1974 Oct; 15(10):1128-32. PubMed ID: 4476809
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the modifications of euglobulin fibrinolysis induced after the administration of a synthetic heparinoid].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1959 Nov; 35():1500-2. PubMed ID: 13807123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolysis: studies on the significance of euglobulin clot lysis time and re-examination of its estimation method].
    Ishii S; Kimura T; Numakami A; Ito S; Azumagawa T; Kikuchi N
    Kanagawa Shigaku; 1985 Sep; 20(2):271-81. PubMed ID: 3869263
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetics of non-activated euglobulin fibrinolysis in human plasma].
    Hindersin P; Zwiener U; Fischer W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(2):293-9. PubMed ID: 4136394
    [No Abstract]   [Full Text] [Related]  

  • 13. Euglobulin fibrinolysis in newborn infants, healthy prematures, and prematures with respiratory distress syndrome (R.D.S.).
    Arustowicz Z
    Ann Paediatr; 1966; 206(4):265-75. PubMed ID: 6012739
    [No Abstract]   [Full Text] [Related]  

  • 14. [Euglobulin lysis time].
    Ohta S; Sakuragawa N
    Nihon Rinsho; 1999 Sep; 57 Suppl():546-7. PubMed ID: 10543173
    [No Abstract]   [Full Text] [Related]  

  • 15. [EFFECTS ON FIBRINOLYTIC ACTIVITY OF TOLBUTAMIDE ADDED "IN VITRO" TO PLASMA AND TO THE EUGLOBULIN FRACTION].
    BELLI C; TESSARI L
    Arch Sci Med (Torino); 1963 Oct; 116():181-7. PubMed ID: 14098152
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.
    Kluft C
    Haemostasis; 1976; 5(3):136-46. PubMed ID: 12071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglobulin lysis times: an update.
    Glassman A; Abram M; Baxter G; Swett A
    Ann Clin Lab Sci; 1993; 23(5):329-32. PubMed ID: 8239479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Difference between serum and euglobulin in the determination of fibrinolytic activity by streptokinase: differences of fibrinolytic activity in various diseases].
    Miyatani K; Fukui I
    Rinsho Byori; 1970 Jul; 18(7):512-4. PubMed ID: 5466544
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of the thromboelastograph for registration of the time of euglobulin lysis in normal rats and those with experimentally modified fibrinolysis].
    Prino G; Mantovani M; Butti A
    Farmaco Prat; 1969 Sep; 24(9):552-61. PubMed ID: 4187112
    [No Abstract]   [Full Text] [Related]  

  • 20. PLASMA EUGLOBULIN LYSIS TIME IN SOME SPECIES OF ANIMALS.
    RAO AR; GOPALAN C
    Indian J Med Res; 1964 Dec; 52():1287-92. PubMed ID: 14264202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.